Sharon Shacham

Direktor/Vorstandsmitglied bei ACRIVON THERAPEUTICS, INC.

Vermögen: 151 119 $ am 31.05.2024

53 Jahre

Health Technology

Consumer Services

Aktive Positionen von Sharon Shacham

Unternehmen	Position	Beginn	Ende
ACRIVON THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	01.10.2020	-
ACRIVON THERAPEUTICS, INC.	Independent Dir/Board Member	01.10.2020	-

Unternehmen	Position	Beginn	Ende
KARYOPHARM THERAPEUTICS INC.	Direktor/Vorstandsmitglied	21.05.2013	21.01.2015
	Technik-/Wissenschafts-/F&E-Leiter	27.12.2010	03.05.2021
	Gründer	22.12.2008	03.05.2021
	Corporate Officer/Principal	22.12.2008	-
	Präsident	12.08.2014	03.05.2021
EPIX Pharmaceuticals, Inc. EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA.	Corporate Officer/Principal	01.01.2000	01.04.2009
Predix Pharmaceuticals, Inc. Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA.	Corporate Officer/Principal	-	-

Tel-Aviv University

Doctorate Degree

International

Vereinigte Staaten	5
Israel	2

Operativ

Corporate Officer/Principal	3
Director/Board Member	2
Doctorate Degree	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
KARYOPHARM THERAPEUTICS INC.	Health Technology
ACRIVON THERAPEUTICS, INC.	Health Technology

Private Unternehmen	2
EPIX Pharmaceuticals, Inc. EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA.	Health Technology
Predix Pharmaceuticals, Inc. Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA.	Health Technology

Private Unternehmen

Health Technology